Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/6/23 → 1/11/26 |
Funding
- BioNTech SE: $73,220.00
COVID-19: BNT-162: An Exploratory Phase 1, Randomized, Observer-Blind, Active-Controlled Dose Escalation Trial Evaluating the Safety, Tolerability and Immunogenicity of an Investigational RNA-based SARS-CoV-2 Vaccine in COVID-19 Vaccine Experienced Health
- Greenberg, Richard (PI)
- Simmons, Christopher (CoI)